Cargando…
Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Japanese Society of Internal Medicine
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381185/ https://www.ncbi.nlm.nih.gov/pubmed/33583906 http://dx.doi.org/10.2169/internalmedicine.6807-20 |
| _version_ | 1783741319090274304 |
|---|---|
| author | Agarwal, Ritesh Muthu, Valliappan |
| author_facet | Agarwal, Ritesh Muthu, Valliappan |
| author_sort | Agarwal, Ritesh |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8381185 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The Japanese Society of Internal Medicine |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83811852021-08-30 Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated? Agarwal, Ritesh Muthu, Valliappan Intern Med Letters to the Editor The Japanese Society of Internal Medicine 2021-02-15 2021-08-01 /pmc/articles/PMC8381185/ /pubmed/33583906 http://dx.doi.org/10.2169/internalmedicine.6807-20 Text en Copyright © 2021 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Letters to the Editor Agarwal, Ritesh Muthu, Valliappan Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated? |
| title | Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated? |
| title_full | Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated? |
| title_fullStr | Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated? |
| title_full_unstemmed | Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated? |
| title_short | Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated? |
| title_sort | benralizumab as a first-line treatment for abpa: is it really indicated? |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381185/ https://www.ncbi.nlm.nih.gov/pubmed/33583906 http://dx.doi.org/10.2169/internalmedicine.6807-20 |
| work_keys_str_mv | AT agarwalritesh benralizumabasafirstlinetreatmentforabpaisitreallyindicated AT muthuvalliappan benralizumabasafirstlinetreatmentforabpaisitreallyindicated |